Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Masahiro Hirakawa"'
Autor:
Ichiro Takemasa, Hiroyuki Ohnuma, Tetsuji Takayama, Tamotsu Sagawa, Hiroshi Miyamoto, Takayuki Nobuoka, Mitsuo Shimada, Yasuo Takahashi, Koshi Fujikawa, Minoru Takahashi, Shinich Katsuki, Masahiro Hirakawa, Junji Kato, Yutaka Okagawa, Koichi Okamoto, Yasushi Sato, Syouhei Kikuch, Minami Shinya, Uemura Naoki, Masahiro Maeda
Publikováno v:
Gastric Cancer. 20:517-526
Conversion therapy is an option for unresectable metastatic gastric cancer when distant metastases are controlled by chemotherapy; however, the feasibility and efficacy remain unclear. This study aimed to assess the feasibility and efficacy of conver
Autor:
Yasushi Sato, Tamotsu Sagawa, Hiroyuki Ohnuma, Junji Kato, Masahiro Hirakawa, Tetsuji Takayama, Koichi Okamoto, Koji Miyanishi, Ichiro Takemasa, Hiroshi Miyamoto, Yasuo Takahashi, Shohei Kikuchi, Takayuki Nobuoka
Publikováno v:
Cancer chemotherapy and pharmacology. 81(3)
Peritoneal metastasis (PM) in advanced or recurrent gastric cancer (AGC) is the most frequent cause of death from this disease. However, current treatments remain unsatisfactory. We previously conducted studies of docetaxel, cisplatin and S-1 (DCS) c
Autor:
Takahiro Osuga, Yasuhiro Sato, Jinsei Miyoshi, Shinich Katsuki, Masahiro Hirakawa, Koichi Hirata, Takayuki Nobuoka, Toshi Takaoka, Rishu Takimoto, Junji Kato, Tomohiro Kubo, Miwako Kagawa, Hiroshi Miyamoto, Tetsuji Takayama, Masayoshi Kobune, Yasuo Takahashi, Toshinori Okuda, Yasushi Sato, Yasuhiro Mitsui, Hiroyuki Ohnuma, Yasuteru Fujino, Tamotsu Sagawa
Publikováno v:
Cancer Chemotherapy and Pharmacology. 76:375-382
We previously reported that a triplet combination of docetaxel, cisplatin, and S-1 (DCS) is active against metastatic gastric cancer with a very high response rate of 87.1 % in a phase II study. Recently, the efficacy of trastuzumab (T-mab) for the t
Autor:
Tamotsu Sagawa, Koji Miyanisi, Koshi Fujikawa, Tetsuji Takayama, Junji Kato, Tetsuro Okamoto, Yasushi Sato, Yasuo Takahashi, Minoru Takahashi, Masahiro Hirakawa, Shinya Minami, Shohei Kikuchi, Kohichi Takada, Toshinori Okuda, Koichi Okamoto, Hiroshi Miyamoto, Hiroyuki Ohnuma, Naoki Uemura
Publikováno v:
Cancer chemotherapy and pharmacology. 80(4)
Triplet therapy using docetaxel, cisplatin, and S-1 (DCS) against unresectable gastric cancer as previously reported by us showed high clinical efficacy, with a 87.1% total response rate; however, it also showed a high incidence of grade 3/4 toxicity
Autor:
Hiroshi Miyamoto, Keisuke Harada, Minoru Takahashi, Tetsuji Takayama, Yasuhiro Sato, Takayuki Nobuoka, Shinich Katsuki, Masahiro Hirakawa, Koji Miyanishi, Koichi Hirata, Hiroyuki Ohnuma, Tamotsu Sagawa, Michihiro Ono, Tsuyoshi Hayashi, Rishu Takimoto, Tsutomu Sato, Yasushi Sato, Junji Kato, Masahiro Maeda, Michiaki Hirayama, Kohichi Takada, Masayoshi Kobune, Yasuo Takahashi
Publikováno v:
Cancer Chemotherapy and Pharmacology. 71:789-797
The combination of docetaxel, cisplatin, and S-1 (DCS) chemotherapy is expected to be a promising regimen for advanced gastric cancer. This study was performed to evaluate the efficacy and safety of neoadjuvant DCS chemotherapy for locally advanced r
Autor:
Masahiro Hirakawa, Kyoko Hamaguchi, Hiroyuki Ohnuma, Koichi Okamoto, Hiroshi Miyamoto, Yasuo Takahashi, Tetsuji Takayama, Tamotsu Sagawa, Koshi Fujikawa, Naoki Muguruma, Yasushi Sato
Publikováno v:
Journal of Clinical Oncology. 36:174-174
174 Background: Although the triplet regimen of docetaxel/cisplatin/S-1 (DCS) has shown promising activity and conversion rate in patients with unresectable metastatic gastric cancer (UMGC) in Japan, it was accompanied by severe adverse events. Recen
Autor:
Y. Takahashi, Makoto Takahashi, Masahiro Hirakawa, Koichi Okamoto, Hiroshi Miyamoto, Tamotsu Sagawa, Tetsuji Takayama, Junji Kato, T. Okuda, Naoki Uemura, Hiroyuki Ohnuma, Koshi Fujikawa, Shohei Kikuchi, S. Minami, Yasushi Sato
Publikováno v:
Publons
Autor:
K. Murase, Junji Kato, Masayoshi Kobune, Tetsuji Takayama, Michiaki Hirayama, Y. Takahashi, Shinich Katsuki, Masahiro Hirakawa, K. Takada, T. Sagawa, Takahiro Osuga, Hiroyuki Ohnuma, Yasushi Sato, R. Takimoto, Shohei Kikuchi, Makoto Takahashi, Y. Okagawa, K. Miyanishi, Tsutomu Sato, M. Maeda
Publikováno v:
European Journal of Cancer. 51:S431
Autor:
Kunihiro, Takanashi, Shinya, Minami, Naoya, Miyajima, Tasuku, Hirako, Masahiro, Hirakawa, Yutaku, Koh, Tadanori, Saitoh, Yoshinori, Ueno, Yutaka, Sasagawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 36(12)
We report a case of 70-year-old man who was admitted to our hospital due to hematemesis in June 2004. He was diagnosed by gastroscopy as having a type III moderately-poorly differentiated adenocarcinoma. A computed tomography (CT) scan revealed multi
Autor:
Masakazu Hori, Kazuyuki Murase, Masahiro Hirakawa, Koji Miyanishi, Tsuyoshi Hayashi, Takahiro Osuga, Koh-ichi Sakata, Masayoshi Kobune, Junji Kato, Hiroyuki Ohnuma, Tsutomu Sato, Rishu Takimoto, Yutaka Okagawa, Tetsuji Takayama, Yasushi Sato, Satoshi Iyama, Yutaka Kawano, Kohichi Takada, Masanori Someya, Tamotsu Sagawa
Publikováno v:
Journal of Clinical Oncology. 33:123-123
123 Background: Definitive chemoradiotherapy is one of the options for advanced esophageal cancer (AEC). However, AEC patient survival remains unsatisfactory. To investigate a regimen of definitive chemoradiotherapy that exerts good local control of